Laurence Turka, MD, joined Rheos as Chief Scientific Officer, following a 30-year academic career as a transplant immunologist, most recently as the Harold and Ellen Danser Professor of Surgery and Professor of Medicine at Harvard Medical School and Massachusetts General Hospital. Among the notable discoveries of Larry’s laboratory were novel approaches to transplantation tolerance, the role of Toll-like receptors in T-cells, and pathways required for the maintenance of regulatory T-cell function. Larry was also an early contributor to the field of T-cell costimulation and helped contribute to the development of abatacept and belatacept for the treatment of rheumatoid arthritis and renal transplantation.
Larry received his MD from the Yale University School of Medicine, trained in Internal Medicine at Yale-New Haven Hospital and in Nephrology at the Brigham and Women’s Hospital/Harvard Medical School. He is a former Chief of the Renal Division at the University of Pennsylvania, President of the American Society of Transplantation, Chair of the NIAID Board of Scientific Counselors, and Editor in Chief of The Journal of Clinical Investigation. He currently serves as Deputy Director of the Immune Tolerance Network and is a Professor of Surgery and Medicine (part-time) at Harvard Medical School. He was elected to membership in the American Society for Clinical Investigation in 1995, and the Association of American Physicians in 2003.